ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ERLOTINIB: products 1 to 14 of 14.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Erlotinib 100mg TabDIN 02461870 | Off-Formulary Interchangeable, not an ODB benefit | $47.4667per source unit | Requirements & sourcesBuild cost plan |
| Apo-Erlotinib 150mg TabDIN 02461889 | Off-Formulary Interchangeable, not an ODB benefit | $71.2000per source unit | Requirements & sourcesBuild cost plan |
| Apo-Erlotinib 25mg TabDIN 02461862 | Off-Formulary Interchangeable, not an ODB benefit | $11.8667per source unit | Requirements & sourcesBuild cost plan |
| Nat-Erlotinib 100mg TabDIN 02483920 | Off-Formulary Interchangeable, not an ODB benefit | $47.4667per source unit | Requirements & sourcesBuild cost plan |
| Nat-Erlotinib 150mg TabDIN 02483939 | Off-Formulary Interchangeable, not an ODB benefit | $71.2000per source unit | Requirements & sourcesBuild cost plan |
| Nat-Erlotinib 25mg TabDIN 02483912 | Off-Formulary Interchangeable, not an ODB benefit | $11.8667per source unit | Requirements & sourcesBuild cost plan |
| PMS-Erlotinib 100mg TabDIN 02454386 | Off-Formulary Interchangeable, not an ODB benefit | $47.4667per source unit | Requirements & sourcesBuild cost plan |
| PMS-Erlotinib 150mg TabDIN 02454394 | Off-Formulary Interchangeable, not an ODB benefit | $71.2000per source unit | Requirements & sourcesBuild cost plan |
| Tarceva 100mg TabDIN 02269015 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Tarceva 150mg TabDIN 02269023 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Tarceva 25mg TabDIN 02269007 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Erlotinib 100mg TabDIN 02377705 | Off-Formulary Interchangeable, not an ODB benefit | $47.4666per source unit | Requirements & sourcesBuild cost plan |
| Teva-Erlotinib 150mg TabDIN 02377713 | Off-Formulary Interchangeable, not an ODB benefit | $71.2000per source unit | Requirements & sourcesBuild cost plan |
| Teva-Erlotinib 25mg TabDIN 02377691 | Off-Formulary Interchangeable, not an ODB benefit | $11.8666per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.